Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 144
- 較 2021 年第 2 季 −9
- 總值
- $4.37 億
- 較 2021 年第 2 季 −$1.23 億 (−22.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 526,500 | $2,190 萬 | 5.0% | +526,500 | 新進 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 1,351,933 | $1,700 萬 | 3.9% | +303,550+29.0% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 270,431 | $1,460 萬 | 3.3% | −95,113−26.0% | 減碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 1,187,898 | $1,445 萬 | 3.3% | +240,770+25.4% | 加碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 2,539,917 | $1,344 萬 | 3.1% | −179,373−6.6% | 減碼 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 573,380 | $1,257 萬 | 2.9% | +28,378+5.2% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 883,046 | $1,148 萬 | 2.6% | +657,908+292.2% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 347,545 | $1,146 萬 | 2.6% | +347,545 | 新進 | 歷史 |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,691,110 | $1,042 萬 | 2.4% | −25,730−0.9% | 減碼 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,750,043 | $999.3 萬 | 2.3% | −230,357−11.6% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 289,850 | $965.4 萬 | 2.2% | +281,774+3,489.0% | 加碼 | 歷史 |
| BIIBBiogen Inc. | COM | 32,243 | $912.3 萬 | 2.1% | −93,719−74.4% | 減碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 211,670 | $789.0 萬 | 1.8% | −19,219−8.3% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 295,111 | $748.6 萬 | 1.7% | −152,999−34.1% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 229,202 | $684.6 萬 | 1.6% | +144,139+169.4% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 92,344 | $615.2 萬 | 1.4% | +92,344 | 新進 | 歷史 |
| AYLAOld Ayala, Inc | COM | 538,939 | $611.2 萬 | 1.4% | +538,939 | 新進 | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 901,362 | $599.4 萬 | 1.4% | −193,662−17.7% | 減碼 | 歷史 |
| BCABBioAtla, Inc. | COM | 196,400 | $578.2 萬 | 1.3% | +126,240+179.9% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 377,438 | $576.7 萬 | 1.3% | −263,168−41.1% | 減碼 | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 1,840,631 | $535.7 萬 | 1.2% | −145,781−7.3% | 減碼 | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 562,246 | $510.5 萬 | 1.2% | +262,246+87.4% | 加碼 | 歷史 |
| CLVSClovis Oncology, Inc. | COM | 1,112,669 | $496.3 萬 | 1.1% | −16,804−1.5% | 減碼 | 歷史 |
| CMRXChimerix Inc | COM | 801,308 | $496.0 萬 | 1.1% | −774,608−49.2% | 減碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 993,481 | $486.7 萬 | 1.1% | +993,481 | 新進 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 281,765 | $468.1 萬 | 1.1% | +71,899+34.3% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 744,616 | $457.2 萬 | 1.0% | −265,929−26.3% | 減碼 | – |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 86,865 | $454.4 萬 | 1.0% | −113,135−56.6% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 172,521 | $425.4 萬 | 1.0% | −2,479−1.4% | 減碼 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 606,554 | $422.2 萬 | 1.0% | +606,554 | 新進 | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM | 315,732 | $410.6 萬 | 0.9% | −9,268−2.9% | 減碼 | 歷史 |
| RCORRenovacor, Inc. | COM | 442,902 | $400.8 萬 | 0.9% | +442,902 | 新進 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 414,174 | $395.4 萬 | 0.9% | +72,674+21.3% | 加碼 | 歷史 |
| MGNXMacrogenics Inc | COM | 188,478 | $394.7 萬 | 0.9% | −271,124−59.0% | 減碼 | 歷史 |
| VSTMVerastem, Inc. | COM | 1,227,371 | $378.0 萬 | 0.9% | −167,023−12.0% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 1,105,082 | $371.5 萬 | 0.9% | −19,790−1.8% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 403,450 | $368.8 萬 | 0.8% | −221,234−35.4% | 減碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 757,545 | $366.6 萬 | 0.8% | +657,545+657.5% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 544,819 | $356.8 萬 | 0.8% | −811,229−59.8% | 減碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 216,519 | $351.6 萬 | 0.8% | +216,519 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM | 509,155 | $343.1 萬 | 0.8% | −7,715−1.5% | 減碼 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 51,500 | $338.7 萬 | 0.8% | +51,500 | 新進 | 歷史 |
| CLNNClene Inc. | COMMON STOCK | 489,321 | $334.2 萬 | 0.8% | +370,788+312.8% | 加碼 | 歷史 |
| ALLKAllakos Inc. | COM | 31,526 | $333.7 萬 | 0.8% | −174−0.5% | 減碼 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 479,995 | $332.1 萬 | 0.8% | −104,809−17.9% | 減碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 199,057 | $321.9 萬 | 0.7% | −227,686−53.4% | 減碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 99,560 | $319.6 萬 | 0.7% | −440−0.4% | 減碼 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 285,264 | $316.0 萬 | 0.7% | −5,270−1.8% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 500,642 | $314.4 萬 | 0.7% | −24,112−4.6% | 減碼 | 歷史 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 27,968 | $313.1 萬 | 0.7% | −91,743−76.6% | 減碼 | 歷史 |
| TCDATricida, Inc. | COM | 670,771 | $311.3 萬 | 0.7% | −104,523−13.5% | 減碼 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 310,110 | $310.9 萬 | 0.7% | −12,620−3.9% | 減碼 | 歷史 |
| ACETAdicet Bio, Inc. | COM | 392,418 | $307.7 萬 | 0.7% | +266,874+212.6% | 加碼 | 歷史 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 40,961 | $306.1 萬 | 0.7% | 00.0% | 不變 | – |
| STSASatsuma Pharmaceuticals, Inc. | COM | 629,384 | $293.4 萬 | 0.7% | −14,672−2.3% | 減碼 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 2,763,583 | $281.8 萬 | 0.6% | −36,417−1.3% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 25,661 | $281.1 萬 | 0.6% | −29,154−53.2% | 減碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 277,551 | $277.5 萬 | 0.6% | −142,022−33.8% | 減碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 134,575 | $254.1 萬 | 0.6% | −785−0.6% | 減碼 | 歷史 |
| LQDALiquidia Corp | COM NEW | 884,893 | $244.2 萬 | 0.6% | −5,542−0.6% | 減碼 | 歷史 |
| TAOXTAO Synergies Inc. | COM NEW | 245,629 | $244.1 萬 | 0.6% | −54,371−18.1% | 減碼 | 歷史 |
| SYBXSynlogic, Inc. | COM | 788,818 | $240.6 萬 | 0.6% | −59,536−7.0% | 減碼 | 歷史 |
| KAKineta, Inc. | COM | 228,761 | $236.0 萬 | 0.5% | +9,291+4.2% | 加碼 | 歷史 |
| INCYIncyte Corp | COM | 32,666 | $224.7 萬 | 0.5% | −3,867−10.6% | 減碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 344,578 | $212.9 萬 | 0.5% | −5,422−1.5% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 1,539,691 | $212.6 萬 | 0.5% | −47,046−3.0% | 減碼 | 歷史 |
| CDAKCodiak BioSciences, Inc. | COM | 119,895 | $195.8 萬 | 0.4% | +119,895 | 新進 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 197,173 | $195.0 萬 | 0.4% | −2,827−1.4% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 23,700 | $189.0 萬 | 0.4% | +46+0.2% | 加碼 | 歷史 |
| GYREGyre Therapeutics, Inc. | COM NEW | 454,346 | $186.7 萬 | 0.4% | −126,854−21.8% | 減碼 | 歷史 |
| QNCXQuince Therapeutics, Inc. | COM | 20,160 | $184.8 萬 | 0.4% | −373−1.8% | 減碼 | 歷史 |
| MXCTMaxcyte, Inc. | COM | 150,000 | $183.1 萬 | 0.4% | +150,000 | 新進 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 421,050 | $170.1 萬 | 0.4% | −5,405−1.3% | 減碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 96,576 | $168.5 萬 | 0.4% | −389−0.4% | 減碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 600,693 | $164.7 萬 | 0.4% | −315,859−34.5% | 減碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 631,048 | $163.4 萬 | 0.4% | −35,548−5.3% | 減碼 | 歷史 |
| NTBLNotable Labs, Ltd. | COM | 790,838 | $162.2 萬 | 0.4% | −9,973−1.2% | 減碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 53,370 | $157.3 萬 | 0.4% | +53,370 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM | 718,705 | $156.6 萬 | 0.4% | −178,625−19.9% | 減碼 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 502,627 | $154.3 萬 | 0.4% | −7,297−1.4% | 減碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 86,712 | $146.4 萬 | 0.3% | −21,988−20.2% | 減碼 | 歷史 |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 1,223,067 | $145.6 萬 | 0.3% | −45,087−3.6% | 減碼 | 歷史 |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 496,756 | $145.1 萬 | 0.3% | −3,244−0.6% | 減碼 | – |
| GRIGRI Bio, Inc. | COM | 198,085 | $144.0 萬 | 0.3% | +58,085+41.5% | 加碼 | 歷史 |
| MBIOMustang Bio, Inc. | COM | 506,033 | $136.0 萬 | 0.3% | −19,970−3.8% | 減碼 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM | 175,000 | $130.3 萬 | 0.3% | +175,000 | 新進 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 150,484 | $127.2 萬 | 0.3% | −3,457−2.2% | 減碼 | 歷史 |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 311,041 | $124.7 萬 | 0.3% | −103,959−25.1% | 減碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 521,155 | $124.6 萬 | 0.3% | −154,520−22.9% | 減碼 | 歷史 |
| QSIQuantum-Si Inc | COM CL A | 144,406 | $120.4 萬 | 0.3% | −15,594−9.7% | 減碼 | 歷史 |
| AGTCApplied Genetic Technologies Corp | COM | 390,394 | $117.5 萬 | 0.3% | −25,490−6.1% | 減碼 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 172,309 | $116.0 萬 | 0.3% | −2,502−1.4% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 50,907 | $112.0 萬 | 0.3% | −316−0.6% | 減碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 948,526 | $96.8 萬 | 0.2% | −15,574−1.6% | 減碼 | 歷史 |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 289,550 | $95.5 萬 | 0.2% | −3,650−1.2% | 減碼 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 111,292 | $87.9 萬 | 0.2% | −2,308−2.0% | 減碼 | 歷史 |
| TPSTTempest Therapeutics, Inc. | COM | 58,803 | $85.1 萬 | 0.2% | −31,062−34.6% | 減碼 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM NEW | 1,228,416 | $84.9 萬 | 0.2% | −17,573−1.4% | 減碼 | 歷史 |
| HEPAHepion Pharmaceuticals, Inc. | COM | 553,273 | $84.7 萬 | 0.2% | −811,786−59.5% | 減碼 | 歷史 |
| ONCTOncternal Therapeutics, Inc. | COM | 199,180 | $83.0 萬 | 0.2% | −1,024−0.5% | 減碼 | 歷史 |
選擇權（51 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $1.29 億 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $8,171 萬 | $3,771 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $2,808 萬 | $4,274 萬 |
| RETAReata Pharmaceuticals Inc | CL A | $4,742 萬 | $1,103 萬 |
| BIIBBiogen Inc. | COM | – | $4,740 萬 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $4,621 萬 |
| UNHUnitedHealth Group Inc | Stock | – | $3,907 萬 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $3,395 萬 |
| SRPTSarepta Therapeutics, Inc. | COM | – | $3,345 萬 |
| RFLRafael Holdings, Inc. | COM CL B | $1,272 萬 | $1,783 萬 |
| KRYSKrystal Biotech, Inc. | COM | $1,527 萬 | $1,474 萬 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | – | $2,533 萬 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | $2,208 萬 | – |
| ChemoCentryx, Inc.16383L106 | COM | $1,026 萬 | $1,026 萬 |
| ALLKAllakos Inc. | COM | $396.0 萬 | $1,596 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | $1,139 萬 | $768.0 萬 |
| KODKodiak Sciences Inc. | COM | – | $1,612 萬 |
| NVAXNovavax Inc | COM NEW | – | $1,451 萬 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | – | $1,333 萬 |
| QNCXQuince Therapeutics, Inc. | COM | – | $1,302 萬 |
| MRTXMirati Therapeutics, Inc. | COM | $23.1 萬 | $1,238 萬 |
| EDITEditas Medicine, Inc. | COM | $1,044 萬 | $205.4 萬 |
| XENEXenon Pharmaceuticals Inc. | COM | $351.5 萬 | $835.3 萬 |
| MRKMerck & Co., Inc. | Stock | – | $1,127 萬 |
| DRNADicerna Pharmaceuticals Inc | COM | – | $995.2 萬 |
| MGNXMacrogenics Inc | COM | – | $934.0 萬 |
| ZGNXZogenix, Inc. | COM NEW | – | $896.8 萬 |
| ARNAArena Pharmaceuticals Inc | COM NEW | – | $885.4 萬 |
| INCYIncyte Corp | COM | – | $678.9 萬 |
| FOLDAmicus Therapeutics, Inc. | COM | $385.4 萬 | $286.5 萬 |
| IGMSIGM Biosciences, Inc. | COM | – | $657.6 萬 |
| ELANElanco Animal Health Inc | COM | – | $637.8 萬 |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $600.6 萬 |
| FATEFate Therapeutics Inc | COM | $592.8 萬 | – |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | – | $540.8 萬 |
| ALDXAldeyra Therapeutics, Inc. | COM | – | $526.8 萬 |
| RLAYRelay Therapeutics, Inc. | COM | $252.2 萬 | $252.2 萬 |
| OCULOcular Therapeutix, Inc | COM | – | $493.2 萬 |
| AVIRAtea Pharmaceuticals, Inc. | COM | $79.9 萬 | $408.8 萬 |
| IOVAIovance Biotherapeutics, Inc. | COM | $483.3 萬 | – |
| AUPHAurinia Pharmaceuticals Inc. | COM | – | $442.6 萬 |
| BCRXBiocryst Pharmaceuticals Inc | COM | – | $359.2 萬 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | – | $348.4 萬 |
| TGTXTG Therapeutics, Inc. | COM | $328.2 萬 | – |
| ISEEIVERIC bio, Inc. | COM | – | $324.8 萬 |
| GOSSGossamer Bio, Inc. | COM | – | $233.0 萬 |
| NKTRNektar Therapeutics | COM | – | $206.2 萬 |
| LONALeonaBio, Inc. | COM | – | $140.7 萬 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | – | $133.9 萬 |
| PTGXProtagonist Therapeutics, Inc | COM | – | $108.3 萬 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | – | $101.2 萬 |
2021 年第 2 季之後清倉（30 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALECAlector, Inc. | COM | 674,723 | $1,405 萬 | 2.5% | 歷史 |
| ANVSAnnovis Bio, Inc. | COM | 103,527 | $886.0 萬 | 1.6% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 295,596 | $761.3 萬 | 1.4% | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 471,376 | $631.2 萬 | 1.1% | – |
| Chardan Healthcr Acqstn 2 Co15957T206 | UNIT 99/99/9999 | 400,000 | $436.9 萬 | 0.8% | – |
| NBPNovaBridge Biosciences | SPONSORED ADS | 46,066 | $386.7 萬 | 0.7% | 歷史 |
| RDNTRadNet, Inc. | COM | 110,647 | $372.8 萬 | 0.7% | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 936,615 | $362.5 萬 | 0.6% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 21,825 | $287.1 萬 | 0.5% | 歷史 |
| CM Life Sciences Inc18978W109 | COM CL A | 200,000 | $280.3 萬 | 0.5% | – |
| ALPNAlpine Immune Sciences, Inc. | COM | 300,454 | $270.4 萬 | 0.5% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 120,895 | $239.3 萬 | 0.4% | 歷史 |
| ICADIcad Inc | COM NEW | 128,137 | $221.9 萬 | 0.4% | 歷史 |
| ZGNXZogenix, Inc. | COM NEW | 124,091 | $214.4 萬 | 0.4% | 歷史 |
| BCELAtreca, Inc. | CL A COM | 250,000 | $213.0 萬 | 0.4% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 162,700 | $170.5 萬 | 0.3% | 歷史 |
| ACIUAC Immune SA | SHS | 196,208 | $155.6 萬 | 0.3% | 歷史 |
| Auris Medical Holding LtdG07025201 | SHS | 404,588 | $144.5 萬 | 0.3% | – |
| LLYEli Lilly & Co | Stock | 5,677 | $130.4 萬 | 0.2% | 歷史 |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 532,298 | $112.4 萬 | 0.2% | – |
| PSTXPoseida Therapeutics, Inc. | COM | 85,837 | $86.1 萬 | 0.2% | 歷史 |
| Affimed N VN01045108 | COM | 93,100 | $79.2 萬 | 0.1% | – |
| KRROKorro Bio, Inc. | COM | 69,879 | $69.6 萬 | 0.1% | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 17,600 | $66.6 萬 | 0.1% | 歷史 |
| ANABAnaptysbio, Inc | COM | 21,553 | $55.8 萬 | 0.1% | 歷史 |
| FLNAFilana Therapeutics, Inc. | COM | 5,362 | $45.8 萬 | 0.1% | 歷史 |
| Chiasma, Inc16706W102 | COM | 90,437 | $42.8 萬 | 0.1% | – |
| TVRDTvardi Therapeutics, Inc. | COM | 29,335 | $41.8 萬 | 0.1% | 歷史 |
| FATEFate Therapeutics Inc | COM | 3,600 | $31.3 萬 | 0.1% | 歷史 |
| Chardan Healthcr Acqstn 2 Co15957T107 | COM | 30,000 | $30.0 萬 | 0.1% | – |